Article: Therapeutic approach to myelofibrosis in the JAK2 inhibitor era

€3.03

SKU: product-article-21129 Category: General

Description
Reviews (0)

Description

Therapeutic approach to myelofibrosis in the JAK2 inhibitor era

Reviews

There are no reviews yet.

Be the first to review “Article: Therapeutic approach to myelofibrosis in the JAK2 inhibitor era”

You must be logged in to post a review.

Top

Article: Therapeutic approach to myelofibrosis in the JAK2 inhibitor era

Description

Reviews

Related products

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in digestive oncology

Article: Highlights in urologic cancer

Article: Highlights in gynaecological cancers